These results indicate that GMCSBHT can treat asthma by inhibiting chemokine secretion, which is associated with eosinophil migration, and inhibiting IL-8, a cytokine that induces eosinophil chemotaxis [34], thereby inhibiting the inflammatory response of eosinophils. This evidence concerns the gene CXCL8 and asthma.